Phase I trial evaluating the pharmacokinetics and metabolic profile of laninamivir octanoate following an inhaled dose administered via TwinCaps.

Trial Profile

Phase I trial evaluating the pharmacokinetics and metabolic profile of laninamivir octanoate following an inhaled dose administered via TwinCaps.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Feb 2013

At a glance

  • Drugs Laninamivir (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacokinetics
  • Sponsors Aviragen Therapeutics
  • Most Recent Events

    • 22 Feb 2013 New trial record
    • 12 Feb 2013 Topline are expected to be available in mid-2013, according to a Biota Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top